Player FM - Internet Radio Done Right
21 subscribers
Checked 3h ago
Aggiunto quattro anni fa
Contenuto fornito da Proactive Investors. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Proactive Investors o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !
Vai offline con l'app Player FM !
Podcast che vale la pena ascoltare
SPONSORIZZATO
At the dawn of the social media era, Belle Gibson became a pioneering wellness influencer - telling the world how she beat cancer with an alternative diet. Her bestselling cookbook and online app provided her success, respect, and a connection to the cancer-battling influencer she admired the most. But a curious journalist with a sick wife began asking questions that even those closest to Belle began to wonder. Was the online star faking her cancer and fooling the world? Kaitlyn Dever stars in the Netflix hit series Apple Cider Vinegar . Inspired by true events, the dramatized story follows Belle’s journey from self-styled wellness thought leader to disgraced con artist. It also explores themes of hope and acceptance - and how far we’ll go to maintain it. In this episode of You Can't Make This Up, host Rebecca Lavoie interviews executive producer Samantha Strauss. SPOILER ALERT! If you haven't watched Apple Cider Vinegar yet, make sure to add it to your watch-list before listening on. Listen to more from Netflix Podcasts .…
Proactive - Interviews for investors
Segna tutti come (non) riprodotti ...
Manage series 2891889
Contenuto fornito da Proactive Investors. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Proactive Investors o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.
…
continue reading
605 episodi
Segna tutti come (non) riprodotti ...
Manage series 2891889
Contenuto fornito da Proactive Investors. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Proactive Investors o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.
…
continue reading
605 episodi
Wszystkie odcinki
×P
Proactive - Interviews for investors

Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to announce significant progress in the company’s Phase 2 clinical study, currently being conducted across nine clinical sites in the United States. The study has now randomized over 50% of its expected 60 patients. The company remains on track to complete an interim data analysis by Q1 2025 and plans to submit its findings to the U.S. Food and Drug Administration (FDA) as part of a Type C meeting request in Q2 2025. The purpose of this meeting is to discuss the clinical development pathway and potentially secure FDA approval to fast-track the program. The SKNJCT-003 clinical trial is a randomized, double-blind, placebo-controlled, multi-center study designed to assess the efficacy of two dose levels of D-MNA in treating basal cell carcinoma (BCC) of the skin. Patients are being randomized into three groups. The 200μg high-dose of D-MNA was previously tested in Medicus Pharma’s Phase 1 safety and tolerability study (SKNJCT-001), completed in March 2021. With enrollment progressing and regulatory discussions on the horizon, Medicus Pharma is positioned to accelerate its clinical program, potentially bringing an innovative treatment for BCC closer to market approval. #proactiveinvestors #nasdaq #mdcx #tsxv #mdcx #pharma #Biotech #CancerTreatment #ClinicalTrials #FDAApproval #SkinCancer #HealthcareInnovation #Investing #MedicalResearch…
P
Proactive - Interviews for investors

1 BioHarvest Sciences surpasses 50 million dollars in VINIA sales, plans major production expansion 7:55
BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to announce a major achievement for the company—VINIA, its flagship red grape cell-based supplement, has now surpassed $50 million in cumulative sales. Notably, the vast majority of these sales have occurred within just four years since the product’s U.S. launch in May 2021, highlighting its rapid market adoption and consumer demand. VINIA®, developed using BioHarvest’s proprietary Botanical Synthesis platform technology, has also reached another key milestone, surpassing 50,000 active U.S. subscribers on recurring subscription plans as of February 16, 2025. This growing base of loyal customers underscores the product’s effectiveness and strong brand resonance in the nutraceutical market. The supplement has garnered widespread consumer approval, with approximately 8,000 verified customer reviews in the U.S. and an impressive rating of 4.8 out of 5 stars. These positive testimonials reflect VINIA’s efficacy and position it as a leader in the functional health supplement category, with strong potential for continued growth both domestically and internationally. Building on this momentum, BioHarvest Sciences is investing in its future scalability. The company has announced plans to expand its production capacity by a factor of four with the construction of a new 100-ton-per-year production facility. This state-of-the-art facility, expected to be operational by late 2026, will enable BioHarvest to meet increasing demand and support its ambitious growth strategy. #proactivinvestors #nasdaq #bhst #pharma #biotech #hearthealth #BioHarvestSciences, #IlanSobel, #RevenueGrowth, #NasdaqListing, #IlanSobel #VINIA #HealthTech #Biotech #Investing #StockMarket #Nasdaq #Polyphenols #Resveratrol #BloodFlow #HealthyLiving #PlantBased #SustainableInnovation…
P
Proactive - Interviews for investors

BitFuFu Vice President of Investor Relations Charley Brady joined Steve Darling from Proactive to discuss the company’s North American expansion and its latest acquisition plans. BitFuFu has signed a letter of intent to acquire a majority stake in a 51-megawatt (MW) Bitcoin mining facility in Oklahoma. Strategically located in an unpopulated area, the fully constructed facility boasts a reliable power supply with an average electricity cost of just 3 cents per kilowatt-hour. The site operates air-cooled Bitcoin miners, delivering high hashrate efficiency to optimize performance and profitability. Brady highlighted that this acquisition aligns with BitFuFu’s goal to expand its global power capacity to 1GW, reinforcing its position as a leader in Bitcoin mining by securing long-term, low-cost, and reliable power sources. In addition to the acquisition, BitFuFu shared its unaudited production update for January 2025 with 83 BTC mined through self-mining operations and 200 BTC generated for cloud-mining customers. The company now holds 1,742 BTC in total holdings as of the end of January. The company also announced an order of 2,000 S21XP miners, set to arrive in the U.S. by March 2025, adding 0.54 exahashes per second (EH/s) of mining capacity. With continued expansion and investment in cutting-edge mining technology, BitFuFu is solidifying its status as a major player in the Bitcoin mining industry. #proactiveinvestors #bitfufuinc #nasdaq #fufu #bitcopins #bitcoinmining #oklamhoma #BitcoinMining #Crypto #Blockchain #MiningExpansion #InvestorNews #CryptoMining #Bitmain #RenewableEnergy #StockMarket NEW…
P
Proactive - Interviews for investors

Nevis Brands CEO John Kueber joined Steve Darling from Proactive to announce a major milestone for the company—the national launch of Happy Apple, a hemp-derived THC beverage designed to offer a smooth, relaxing experience without the drawbacks of alcohol. Already a popular choice in Washington State’s regulated dispensary market, Happy Apple will now be available in dozens of states across the U.S., marking a significant expansion for Nevis Brands. The company has successfully adapted its well-loved formula—a natural, sparkling apple beverage—by replacing the traditional THC component with a hemp-derived alternative. This shift ensures compliance with federal regulations while maintaining the same refreshing taste and enjoyable effects that made Happy Apple a standout product in the cannabis beverage market. Kueber highlighted that under the 2018 Farm Bill, hemp-based products containing less than 0.3% Delta-9 THC are federally legal in the United States. This regulatory clarity has opened the door for thousands of mainstream retailers, including major liquor store chains, to stock hemp-derived THC beverages. The demand for these products is surging, with market research firm Brightfield Group reporting that the hemp-derived cannabis beverage sector generated $382 million in sales in 2024. This market is projected to nearly double, reaching approximately $750 million in the U.S. by 2029. Unlike its traditional licensing model, where Nevis Brands partners with third-party producers to bring its products to market, the company is taking a more direct approach with the Happy Apple hemp-derived line. Nevis is managing sales and distribution through a combination of strategic partnerships with distributors and direct-to-consumer online sales. This shift allows the company to retain a larger share of revenues while strengthening its brand presence in the rapidly growing hemp-based beverage industry. With a proven product and an expanding national footprint, Nevis Brands is well-positioned to capitalize on the rising demand for hemp-derived THC beverages, providing consumers with an innovative, alcohol-free alternative for relaxation and social enjoyment. #proactiveinvestors #nevisbrandsinc #cse #nevi #otcqb #nevif #majorbrand #cannabis #THC #Hemp #CannabisIndustry #HappyApple #THCBeverage #CannabisBusiness #CBD #HempDrink #CannabisInvesting…
P
Proactive - Interviews for investors

Kairos Pharma CEO John Yu joined Steve Darling from Proactive to share major updates on the company’s latest cancer research developments. A significant milestone in its academic partnership with Cedars-Sinai Medical Center has been achieved, as Cedars-Sinai secured $600,000 in funding from the Department of Defense’s Lung Cancer Research Program. This grant will accelerate work on an innovative therapy designed to address chemotherapy resistance and cachexia—a severe condition causing muscle loss and weight depletion in cancer patients. The funding will support efforts to develop a first-in-class treatment aimed at counteracting muscle atrophy, improving physical strength, and enhancing the effectiveness of existing cancer therapies. By targeting key biological pathways linked to cachexia, this therapy could provide much-needed support for cancer patients striving to maintain their health and resilience throughout treatment. In a further expansion of its clinical initiatives, Kairos Pharma has added the prestigious Huntsman Cancer Institute in Salt Lake City, Utah, as a new site for its ongoing Phase 2 clinical trial evaluating an advanced antibody therapy for castrate-resistant prostate cancer. This trial, backed by both Kairos Pharma and a grant from the National Cancer Institute, is assessing whether the therapy can overcome treatment resistance by targeting a key protein involved in disease relapse. With continued progress in both research and clinical trials, Kairos Pharma is reinforcing its commitment to pioneering new approaches in cancer treatment, offering hope to patients facing some of the most challenging forms of the disease. #proactiveinvestors #kairospharmalitd #nyseamerican #kapa #cancer #env105 #CancerResearch #ProstateCancer #LungCancer #ClinicalTrials #Biotech #Immunotherapy #Healthcare #PharmaInnovation #DrugDevelopment…
P
Proactive - Interviews for investors

KEFI Gold and Copper PLC (AIM:KEFI, OTC:KFFLF) executive chairman Harry Anagnostaras-Adams talked with Proactive's Stephen Gunnion about the company’s latest resource update for the Hawiah project in Saudi Arabia. He highlighted that the total reported resource at Hawiah has now reached 3 million ounces of gold equivalent, with the potential to double based on new exploration licenses. He noted that this reinforces the project’s status as a key development asset in Saudi Arabia. Anagnostaras-Adams also discussed the upcoming resource update for Jibal Qutman, which was previously estimated at 700,000 ounces and is expected to increase, improving resource classification. He explained that KEFI has been actively realigning its business plan, enhancing management in Saudi Arabia, and focusing on growth in exploration licenses. He also commented on Ethiopia’s evolving economic landscape, mentioning that the African Union meeting in Addis Ababa has reinforced a positive sentiment. He noted that Ethiopia is attracting investment again after recent economic reforms, including currency liberalisation. KEFI’s banking partners were present at the meetings, and discussions on project financing remain on track. For more insights from KEFI Gold and Copper, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for future updates. #KEFIGold #MiningUpdates #SaudiGold #EthiopiaInvestment #HawiahProject #JibalQutman #GoldExploration #MiningNews #AfricanInvestment #ProactiveInvestors…
P
Proactive - Interviews for investors

ImmuPharma PLC (AIM:IMM) CEO Tim McCarthy joined Stephen Gunnion in the Proactive studio with more on the company’s recent £2.91 million oversubscribed equity fundraising. McCarthy emphasised that this year marks a major turning point for ImmuPharma, building on extensive work from the past two to three years. The fundraising was primarily backed by long-standing investors, including Lanstead, which contributed two-thirds of the total. McCarthy highlighted that the funding will accelerate development within the company’s P140 autoimmune platform, strengthening its position in ongoing discussions with potential pharmaceutical partners. Reflecting on market sentiment, McCarthy noted the strong share price response following ImmuPharma’s January update, where the company detailed its autoimmune platform’s broad potential. The CEO also addressed the company’s structured funding agreement with Lanstead, explaining how share price performance could significantly impact the total funds received. “We have lots more news flow coming down the line,” McCarthy stated, adding that the company aims to demonstrate shareholder value creation in 2025. Watch the full interview to hear more about ImmuPharma’s strategy and future plans. Don’t forget to like this video, subscribe to Proactive’s channel, and turn on notifications for more updates. #ImmuPharma #Biotech #Investing #Pharmaceuticals #Fundraising #Autoimmune #StockMarket #BiotechStocks #TimMcCarthy #ProactiveInvestors…
P
Proactive - Interviews for investors

Gelion PLC (AIM:GELN) CEO John Wood talked with Proactive's Stephen Gunnion about the company’s latest advancements in battery technology. Wood discussed Gelion’s progress, including the release of GEN 3 results achieving 400 Wh/kg, commercial agreements with Glencore and Ionblox Inc., and a £1 million contract with Group Energy Pty Ltd. A key focus was Gelion’s development of sulfur cathodes, which are lighter, safer, and more cost-effective than traditional battery materials. Wood highlighted the company’s ability to pair sulfur cathodes with both liquid and solid-state electrolytes, enhancing their commercial viability. “We actually were able to show that the same sulfur material would work with both liquid and solid-state electrolytes,” he said, emphasising the potential for high-performance, lightweight battery applications. Wood also outlined the next steps, which include advancing partnerships, integrating their technology into the supply chain, and progressing towards commercialisation. Investors should watch for updates on revenue-generating projects and the company’s ongoing work in recycling and zinc battery technology. For more interviews and updates, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for future updates. #Gelion #BatteryTech #EnergyStorage #SulfurBatteries #SolidState #RenewableEnergy #JohnWood #ProactiveInvestors #SustainableTech #LithiumBattery…
P
Proactive - Interviews for investors

Learning Technologies Group PLC (AIM:LTG, OTC:LTTHF) chief executive Jonathan Satchell talked with Proactive's Stephen Gunnion about the company’s transition to private ownership following its acquisition by private equity group General Atlantic. Satchell reflected on LTG’s journey from its 2013 listing to its rapid growth, driven by acquisitions and strong investor backing. However, he noted that the last three years brought challenges, including market shifts and a declining share price, which ultimately led to the company’s decision to go private. He emphasised the role of independent board members in determining the deal’s fairness for shareholders, with a substantial premium over the prior stock price. Discussing the future, Satchell highlighted General Atlantic’s expertise in technology and North America, which aligns well with LTG’s predominantly U.S.-based operations. He acknowledged the potential impact of US policy changes, particularly in diversity and inclusion programs, but remained optimistic about LTG’s growth prospects. Reflecting on London’s public markets, Satchell expressed mixed emotions, stating, “The public markets have been exceptionally supportive for LTG in the first eight years of its journey, but the environment changed completely.” He urged the London market to regain its confidence and appeal for growth companies. For more insights, watch the full interview. Don’t forget to like this video, subscribe to our channel, and turn on notifications for the latest updates from Proactive. #LearningTechnologiesGroup #JonathanSatchell #LTG #GeneralAtlantic #StockMarket #PrivateEquity #MergersAndAcquisitions #BusinessNews #InvestorInsights #ProactiveInvestors…
Cobalt Blue Holdings Ltd (ASX:COB, OTC:CBBHF) investor relations representative Joel Crane talked with Proactive’s Tylah Tully about the company’s earn-in for the Halls Creek Project and its proposal to rebrand as Core Blue Minerals Ltd. Crane explains that Halls Creek is a significant polymetallic copper resource with notable zinc and silver grades. The project is located in a well-established mining jurisdiction and comes with existing mining leases, positioning the company ahead in the permitting process. Discussing the acquisition, Crane outlined three key benefits: Leveraging expertise – The company will apply metallurgical innovations from its Broken Hill Demonstration Plant. Resource potential – The project has high-grade extension opportunities and unassessed cobalt, aligning with the company’s Kwinana cobalt refinery strategy. Commodity diversification – Adding copper exposure helps mitigate single-commodity risks while supporting the energy transition. Crane also explained the reasoning behind the proposed name change to Core Blue Minerals Ltd, noting that the company is expanding beyond cobalt. Despite the broader focus, the company remains committed to its core projects, including the Kwinana Cobalt Refinery and Broken Hill Cobalt Project. #CobaltBlue #MiningNews #Copper #Cobalt #HallsCreek #BatteryMetals #EnergyTransition #CommodityMarkets #MiningInvestment #ResourceDevelopment…
P
Proactive - Interviews for investors

Riversgold Ltd has exercised its option to acquire an 80% interest in the Kalgoorlie Gold Project’s Northern Zone in Western Australia after meeting the required A$600,000 minimum exploration expenditure. The company has formally notified Oracle Power Plc (LON: ORCP), the current owner, in accordance with ar Heads of Agreement signed in May 2023. Exploration efforts have identified a significant blind porphyry gold system, with widths of up to 600 metres and mineralisation extending beyond 400 metres in depth. Recent shallow drilling has detected gold mineralisation from approximately 30 metres below the surface, while metallurgical testing has reported an average gold recovery of 92.9% through a 24-hour bottle roll extraction process. With the 2025 drilling program set to begin, Riversgold aims to further explore the deposit, upgrade the tenement status to a Mining Lease and evaluate its potential as a contract mining, trucking and toll milling operation. The company is focused on establishing a robust mineral resource estimate for the upper section of the porphyry to assess the feasibility of an economic starter pit. Riversgold and Oracle have extended their joint venture agreement deadline to December 31, 2025, to facilitate the Mining Lease application. A drill rig has been secured, with drilling set to commence in the coming weeks. #Riversgold #KalgoorlieGold #GoldMining #MiningExploration #WesternAustralia #GoldProject #Drilling #MineralExploration #PorphyryGold #MiningLease #ExplorationUpdate #MiningNews #Geology #GoldMineralisation…
P
Proactive - Interviews for investors

Ionic Rare Earths Ltd has reported a potential 30-50% reduction in the carbon footprint of its rare earth oxide (REO) production compared to conventional producers. A preliminary Life Cycle Assessment (LCA) conducted by Minviro on the magnet recycling process of subsidiary Ionic Technologies has highlighted significant environmental benefits. The results are undergoing peer review, with final findings expected in March 2025. Ionic Technologies’ Belfast commercial recycling plant will focus on Didymium oxide ((NdPr)₂O₃) and Dysprosium oxide (Dy₂O₃), with additional analysis on Neodymium oxide (Nd₂O₃). The study also assessed the environmental impact of applying IXR’s magnet REO products in direct drive wind turbine generators using Rare Earth Permanent Magnet (REPM) technology. The company aims to support a more sustainable rare earth supply chain, particularly in Europe, reducing dependence on Chinese markets. IXR is working with Less Common Metals and Ford Technologies to establish a UK-based recycled magnet supply chain, with Ford using these materials at its EV drive train facility in Halewood. Ionic Rare Earths expects the final study results to reinforce the advantages of its patented process and strengthen its position in decarbonising rare earth supply chains. #IonicRareEarths #RareEarths #MagnetRecycling #SustainableMining #ESG #CO2Reduction #Decarbonisation #ElectricVehicles #WindEnergy #GreenManufacturing #CircularEconomy #CriticalMinerals #NetZero #EnvironmentalImpact #CarbonFootprint #RenewableEnergy #SupplyChain #Recycling #AdvancedManufacturing #MiningInnovation…
P
Proactive - Interviews for investors

Asian Battery Metals PLC has identified priority drilling areas at the Oval Copper-Nickel Project in southwest Mongolia ahead of its Phase 3 exploration program, scheduled to begin next month. The program will include up to 1,500 metres of diamond drilling, downhole electromagnetic (DHEM) surveys and regional geophysical surveys. Drilling will focus on untested or modified DHEM conductive plates identified from the Phase 2 exploration work. Additionally, the company will investigate a high gravity inversion anomaly and conduct targeted exploration in six step-out drilling areas within the detailed exploration zone. According to the company, the 2025 Phase 3 program aims to further assess the extent of magmatic copper and nickel sulphide mineralisation within the tenement. The key objectives are to refine the understanding of the high-grade zone in the Oval gabbroic body, test deeper extensions of the intrusion based on geophysical data, and conduct scout drilling on additional anomalies. #AsianBatteryMetals #MiningExploration #Copper #Nickel #Mongolia #Drilling #Geophysics #MineralExploration #DiamondDrilling #Phase3Exploration #BatteryMetals #ResourceDevelopment #MiningNews #Geology #ElectromagneticSurveys #GravityAnomalies #GabbroicIntrusion #SoilSampling #MagmaticMineralisation #MiningIndustry…
P
Proactive - Interviews for investors

Recce Pharmaceuticals Ltd (ASX:RCE, FSE: R9Q) director & chief medical advisor Dr Alan Dunton and executive chairman Dr John Prendergast talked with Proactive’s Tylah Tully about the company’s latest Phase 2 clinical trial results for RECCE® 327, a topical gel targeting Diabetic Foot Infections (DFIs) and Acute Bacterial Skin and Skin Structure Infections (ABSSSI). Dr Dunton explained that the Phase 2 study was conducted across three sites in Australia, testing the gel in 30 patients. The results showed a 93% cure or improvement rate after two weeks of treatment, with 82% of patients responding positively within the first week. He highlighted the gel’s strong efficacy, noting that unlike many antibiotics, R327G did not develop bacterial resistance. Dr Prendergast emphasised that these findings provided confidence as Recce moved toward regulatory approval. He revealed that the upcoming registration Phase 3 trial in Indonesia, originally planned for 300 patients, may achieve meaningful interim data in as few as 100 patients. This could fast-track approval within a shorter timeframe, potentially 12 months. Both executives underscored the clinical potential of R327G, particularly in tackling antibiotic-resistant infections. With its first-in-class synthetic antibiotic properties, the gel could become a game-changer in infection treatment. #ReccePharmaceuticals #ASXRCE #Biotech #ClinicalTrials #Recce327 #Antibiotics #DiabeticFootUlcer #ABSSSI #DrugDevelopment #MedicalResearch #StockMarket…
P
Proactive - Interviews for investors

Tonix Pharmaceuticals CEO Dr. Seth Lederman joined Steve Darling from Proactive to discuss promising topline results from the company's Phase 1, single ascending dose trial of TNX-1500 in healthy participants. The trial evaluated safety, tolerability, pharmacokinetics, and pharmacodynamics of intravenous TNX-1500 and was designed to support dosing for an upcoming Phase 2 trial in kidney transplant recipients. Two published studies in the American Journal of Transplantation demonstrated that TNX-1500 can prevent rejection, prolong survival, and preserve graft function in non-human primate renal and heart allografts, either as a single agent or in combination with other therapies. Dr. Lederman shared that Phase 1 results showed TNX-1500 at 10 mg/kg and 30 mg/kg doses effectively blocked both primary and secondary antibody responses to a test antigen. Pharmacokinetic data suggest that monthly dosing at 10 mg/kg or higher could be effective. These findings reinforce the company’s confidence in TNX-1500’s potential to prevent organ transplant rejection and improve graft survival with a lower long-term toxicity burden compared to existing immunosuppressive therapies. Tonix plans to present these results to the U.S. Food and Drug Administration (FDA) in an End-of-Phase 1 meeting. Pending FDA alignment, the company will move forward with a Phase 2 efficacy study in kidney transplant recipients. #proactiveinvestors #tonixpharmaceuticalsholdingcorp #nasdaq #tnxp #TonixPharmaceuticals #Biotech #FDA #FDAApproval #TNX1500 #MonoclonalAntibodies #OrganTransplant #AutoimmuneDisease #MedicalResearch #PharmaNews #HealthcareInnovation…
Ondo InsurTech PLC CEO Craig Foster talked with Proactive's Stephen Gunnion about the company’s continued expansion in the US, following the latest agreement with Privilege Underwriters Reciprocal Exchange (PURE). The high-net-worth insurer has expanded its use of Ondo’s LeakBot technology beyond its pilot in New York into six more states—Indiana, North Carolina, New Jersey, Ohio, Pennsylvania, and Washington. Foster explained that PURE initially wanted to test the company’s customer service capabilities, given its clientele of affluent homeowners. He noted that Ondo has already proven its ability to meet high standards, having worked with UK-based high-net-worth insurers such as Hiscox. Discussing the broader US expansion, Foster highlighted that this marks the latest partnership to scale up since Nationwide expanded LeakBot into 16 states. Ondo follows a state-by-state expansion model, securing lead partners in each new region before adding more insurers to drive further adoption. Looking ahead, Foster will travel to Tennessee for a key industry think tank, a strategy inspired by Whisker Labs' success in growing its own home safety technology across the US. Foster emphasized that the company faces no direct competition in a $17 billion market, presenting a major opportunity for growth. For more exclusive interviews, subscribe to Proactive’s YouTube channel, like the video, and enable notifications for updates. #OndoInsurTech #LeakBot #USExpansion #InsuranceTech #HomeProtection #PUREInsurance #CraigFoster #ProactiveInvestors #WaterDamage #TechInnovation #InvestorUpdates…
hVIVO PLC chief executive Yamin ‘Mo’ Khan talked with Proactive's Stephen Gunnion about the company’s newly inked £2 million contract with a biotech client. The deal will fund the final stage of hVIVO’s human metapneumovirus (hMPV) characterisation study, paving the way for future human challenge trials. Khan explained that hVIVO had already completed a successful pilot study involving a small group of volunteers. The new study will expand the trial to a larger population to confirm infection levels and establish a robust challenge model for hMPV research. “This, hopefully, if successful, will go a long way in accelerating the development of an hMPV vaccine,” Khan stated. He emphasised that there are currently no approved vaccines or treatments for hMPV, which has been gaining media attention due to its increasing prevalence in children. The study, which was not included in hVIVO’s year-end sales pipeline, came as a new business opportunity in early 2025. hVIVO expects to complete the characterisation study by June, with commercial human challenge trials potentially beginning in the second half of the year. Stay tuned for more updates on hVIVO’s research progress. Don’t forget to like this video, subscribe to Proactive’s YouTube channel, and enable notifications for more exclusive interviews. #hVIVO #Biotech #hMPV #ClinicalTrials #VaccineResearch #MedicalInnovation #Healthcare #Investing #Pharmaceuticals #ProactiveInvestors…
P
Proactive - Interviews for investors

International Graphite (ASX: IG6) has completed successful purification test-work on graphite from its Springdale Graphite Project in Western Australia. The test-work, coordinated by Japan’s Marubeni Corporation, achieved total graphitic carbon (TGC) purity of up to 99.97%, meeting lithium-ion battery anode specifications. The bench-scale program used graphite concentrates from drilling and bulk concentrate extraction conducted in 2023. Further purification test-work is planned. Marubeni, one of the world's largest integrated trading and investment conglomerates, is seeking to expand its access to critical minerals, including graphite, to support Japan’s battery and motor vehicle manufacturing industries. Representatives from Marubeni recently visited the Springdale Graphite Project and the Collie Graphite Processing and R&D Facility to progress discussions on collaboration under the existing non-binding memorandum of understanding (MoU) between the companies. This MoU covers potential graphite supply and financial support for International Graphite’s mine-to-market strategy. International Graphite stated that partnering with Marubeni strengthens confidence in its assets and development strategy. The company emphasised that Japan’s battery industry required new sources of graphite, and IG6 offered a secure and reliable Australian supply. #InternationalGraphite, #Marubeni, #Graphite, #BatteryMaterials, #LithiumIon, #GraphitePurification, #SpringdaleGraphite, #CollieGraphite, #CriticalMinerals, #Mining, #AustraliaMining, #BatteryIndustry, #GraphiteProcessing, #ElectricVehicles, #EVBatteries, #MineralResources, #JapanIndustry, #GraphiteSupply, #MiningTechnology, #BatteryManufacturing…
P
Proactive - Interviews for investors

Recce Pharmaceuticals Ltd has received positive Phase II clinical trial results for RECCE® 327 Topical Gel (R327G) in treating Acute Bacterial Skin and Skin Structure Infections (ABSSSI), including Diabetic Foot Infections (DFI). The study achieved a 93% primary efficacy endpoint over 14 days, with an interim response rate of 86% at seven days. No serious adverse events were reported. These results support Recce’s upcoming Phase III registrational study for DFI in Indonesia, which has been approved by the Indonesian Drug and Food Regulatory Authority. An interim analysis is expected in 2025, with full trial completion anticipated by the end of the year. Recce will also advance to a Phase III trial for ABSSSI and DFI in Australia. Recce aims for an accelerated commercialisation pathway by 2026. The global ABSSSI treatment market was valued at US$7.3 billion in 2018 and is projected to reach US$26 billion by 2032. The trial followed FDA standards, using recognised diagnostic tools to assess treatment efficacy. The findings reinforce R327G’s potential as a broad-spectrum anti-infective to address antimicrobial resistance. #ReccePharmaceuticals, #ClinicalTrials, #Phase2Trial, #Antibiotics, #AntimicrobialResistance, #SkinInfections, #DiabeticFootInfections, #MedicalResearch, #Pharmaceuticals, #Healthcare, #DrugDevelopment, #FDAApproval, #Biotech, #MedicalInnovation, #WoundCare, #R327G, #BacterialInfections, #PharmaIndustry, #AustraliaHealthcare, #GlobalHealth…
P
Proactive - Interviews for investors

D3 Energy Ltd (ASX: D3E, OTCQB: DNRGF) has been granted three new Technical Cooperation Permits (TCPs) adjacent to its flagship exploration permit ER315 in South Africa The new permits, TCP258, TCP259 and TCP260, cover a combined area of more than 5,700 hectares, expanding the company’s exploration footprint in a key helium province. These newly acquired TCPs provide additional low-cost exploration and appraisal opportunities. Previous appraisal work at ER315 has demonstrated promising results, with helium samples of up to 6.2% confirmed during production testing of multiple boreholes at shallow depths. The TCPs are valid for one year and will involve low-cost desktop studies. Upon completion of these studies, D3 Energy may apply for Exploration Rights over the relevant areas. #D3Energy, #HeliumExploration, #NaturalGas, #EnergyResources, #Mining, #ExplorationPermits, #ResourceDevelopment, #HeliumIndustry, #EnergySector, #Methane, #MiningInvestment, #GasExploration, #SustainableEnergy, #HeliumProduction, #ASX, #OTCQB, #ResourceExploration, #EnergyMarkets, #MiningTechnology, #ExplorationRights…
P
Proactive - Interviews for investors

Pantoro Ltd (ASX:PNR, OTC:PNTOF) managing director Paul Cmrlec talked with Proactive’s Tylah Tully about the company’s ongoing resource growth program at the Norseman Gold Project in Western Australia and the latest high-grade drilling results. Cmrlec noted that Pantoro’s growth drilling campaign, which began last year with a 38,000-metre program, was progressing well. The company is targeting multiple structures to optimise resource access, and so far, results have met expectations. He confirmed that Pantoro was advancing the rehabilitation of the Bullen Decline, with underground drilling expected to commence in March. Multiple drill rigs are already operational, supporting the company’s growth strategy. Looking ahead, Pantoro plans to continue drilling non-stop for the next couple of years, with four underground drill rigs expected on-site soon. The focus remains on expanding through the Scotia area, with a goal of establishing two additional underground mines. Cmrlec emphasised that alongside expansion, Pantoro remains committed to maintaining strong cash flow and delivering operational success. #Pantoro #ASXPNR #GoldMining #NorsemanGoldProject #DrillingResults #GoldExploration #MiningNews #WesternAustralia #ProactiveInvestors…
P
Proactive - Interviews for investors

Sprintex Ltd (ASX:SIX) managing director Jay Upton talked with Proactive’s Tylah Tully about the company’s latest commercial development, the completion of commissioning of compressor operations for Mest Water in the Netherlands. Upton explained Sprintex had been working with Mest since mid-2024, with a key team recently visiting Europe to oversee the commissioning process. "It is great news that we've got the system going as we would like," Upton said, highlighting the innovative nature of the Mest Water compressor system. Now that the performance and efficiency of the systems have been validated, Mest Water is moving into full-scale production, with plans to meet significant demand. This strategic collaboration is focused on developing a custom compressor for reducing ammonia emissions from agriculture. Upton noted that the Netherlands alone had approximately 22,000 pig and cattle farms, representing a major market opportunity. Beyond its work with Mest Water, Upton shared updates on Sprintex’s broader commercial strategy, including new distributor agreements in the UK, Turkey and India. He also discussed India’s growing focus on hydrogen production from biogas, an area where Sprintex sees additional opportunities. Looking ahead, the company is preparing to showcase its G-Series industrial compressor at the Hannover trade fair in Germany. #Sprintex #ASXSIX #MestWater #Hydrogen #CleanEnergy #CompressorTech #SustainableFarming #IndustrialInnovation #EnergyEfficiency #Biogas…
NextEnergy Capital group lead for nature Hing Kin Lee talked with Proactive's Stephen Gunnion about the company’s commitment to protecting and enhancing natural ecosystems. He discussed how NextEnergy Group integrates nature-focused strategies into its solar and energy storage assets, ensuring long-term sustainability. Lee explained the company's recently launched nature strategy, which addresses environmental risks and opportunities linked to its operations. The strategy aligns with global standards such as the Taskforce on Nature-related Financial Disclosures (TNFD) and the Science Based Targets Network (SBTN). Key targets include no conversion of natural ecosystems, responsible land use, nature restoration, and supply chain transparency. Lee emphasised the dual benefits of clean energy generation and biodiversity enhancement, noting that integrating agriculture with solar (agrivoltaics) can improve land use efficiency. He also highlighted how NextEnergy Capital is exploring natural capital markets and potential financial opportunities from biodiversity gains. “Since 2014, NextEnergy Capital has been absolutely committed to protecting, conserving, and enhancing natural ecosystems,” said Lee. He believes the company’s nature strategy strengthens its ESG performance and provides additional value for investors. For more insights from industry leaders, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for future updates! #NextEnergyCapital #RenewableEnergy #Sustainability #SolarEnergy #ESG #ClimateAction #Biodiversity #NatureStrategy #TNFD #GreenInvesting…
P
Proactive - Interviews for investors

S&U PLC (LSE:SUS) chairman Anthony Coombs takes Proactive's Stephen Gunnion through the company’s latest trading update, highlighting positive momentum in its Advantage and Aspen businesses. Coombs noted that Advantage, S&U’s motor finance division, has seen improvements in collections and efficiency, aided by an easing in regulatory restrictions. He acknowledged ongoing uncertainties, particularly regarding the Supreme Court’s upcoming review on commission disclosure, which has impacted the UK’s motor finance sector. However, he expressed confidence that the business remains strong, with better customer engagement through the newly launched site. Discussing Aspen, S&U’s property finance division, Coombs highlighted a strong performance with over 50% profit growth. He attributed this success to sustained demand for residential property and a favourable interest rate outlook. Coombs remains cautiously optimistic about the future, citing early signs of regulatory changes having a positive impact on operations. "The efficiencies and the change in techniques that were brought about by regulations is beginning to have some beneficial effect," he stated. For more interviews with industry leaders, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for updates. #S&U #MotorFinance #PropertyFinance #Investing #Regulations #UKFinance #Aspen #Advantage #AnthonyCoombs #TradingUpdate…
P
Proactive - Interviews for investors

Empire Metals Ltd Managing Director Shaun Bunn talked with Proactive's Stephen Gunnion about the latest advancements at the company’s Pitfield project in Western Australia. Bunn highlighted that the team has made significant progress in mineral separation and hydrometallurgical test work, rapidly moving through the process flow sheet. He explained that early lab testing on ore samples collected last year has demonstrated successful separation of titanium-bearing minerals and the development of a high-value product. A key milestone has been the recovery of over 91% of titanium through acid digestion, marking a crucial step toward defining a final product specification. Bunn further outlined the next steps, which include scaling up test work from small batch processing to industrial levels by collecting and processing 50 to 80 tonnes of material. This will allow the company to generate bulk samples for potential customers and partners, reinforcing Pitfield’s potential as a major titanium project. He emphasised that the chemistry and technical aspects of the project are coming together well, and investors can expect further updates as larger-scale test work progresses. For more updates on Empire Metals Ltd and other mining developments, visit Proactive’s YouTube channel. Don't forget to like this video, subscribe to our channel, and turn on notifications for future updates. #EmpireMetals #Mining #Titanium #PitfieldProject #ShaunBunn #Investing #MineralExploration #Hydrometallurgy #AustralianMining #MiningNews…
P
Proactive - Interviews for investors

Mode Mobile CEO Dan Novaes joined Steve Darling from Proactive to discuss how the company is redefining smartphone usage by enabling users to earn rewards for everyday activities. Unlike major tech companies like Facebook, Apple, and Google, which profit from user data, Mode Mobile returns value directly to consumers. The company’s software rewards users for tasks they already do, such as playing games, reading news, trading stocks, or even charging their phones. Available on any Android device, Mode Mobile also offers its own branded smartphones, which are sold at major retailers like Walmart and Best Buy. Novaes compared Mode Mobile’s business model to Roku’s, which earns revenue from streaming rather than hardware sales. By partnering with advertisers, the company allows users to earn rewards while engaging with content. “If you think about what Uber did for cars or Airbnb did for homes, we believe we’re creating a new asset class for smartphones,” Novaes said. Looking ahead, Mode Mobile is raising capital and has reserved the ticker symbol “MODE” with Nasdaq, signaling a potential public listing. With over 33,000 shareholders and a vision to tap into a multi-billion-dollar market, Mode Mobile is poised for significant growth in the evolving mobile rewards economy. #proactiveinvestors #ModeMobile #SmartphoneRewards #TechInnovation #DanNovaes #PassiveIncome #EarnWithYourPhone #DigitalEconomy #AdRevenue #TechStocks #MobileApps…
P
Proactive - Interviews for investors

1 2025.02.14 Corero Network SeCorero Network Security unveils 2025 strategy for global expansion & cybersecurity solutions 6:14
Corero Network Security CEO Carl Herberger joined Steve Darling from Proactive to discuss the company’s strategic vision for 2025, emphasizing global expansion, innovation, and the evolving cybersecurity landscape. Herberger outlined Corero’s increasing global footprint, with new sales offices opening in the Middle East, Latin America, and the Asia-Pacific region, reinforcing the company’s commitment to expanding its market reach. A key highlight of Corero’s strategy is the Core platform, which enhances distributed denial-of-service (DDoS) protection by integrating complementary cybersecurity solutions. “Our customers no longer need to go elsewhere for additional security solutions—we’re bringing everything into our portfolio,” Herberger stated, signaling a shift toward a more comprehensive cybersecurity approach. As AI-driven computing continues to grow, so does the demand for advanced data center security. Herberger emphasized that Corero is well-positioned to meet these demands, thanks to its strong partnerships with industry leaders like Akamai and Juniper Networks. He also projected rapid growth in Net Revenue Retention (NRR) for 2025, reflecting the company’s expanding customer base and increasing adoption of its solutions. With a strong focus on execution, Corero aims to drive sales and strengthen its market presence in the rapidly evolving cybersecurity sector, positioning itself as a key player in the fight against modern cyber threats. #proactiveinvestors #coreronetworksecurity #aim #cns #otcqx #ddosf #DDoSProtection #Corero #AI #NetworkSecurity #TechInnovation #DataCenters #CyberThreats #CloudSecurity #TechNews…
P
Proactive - Interviews for investors

Sprott Director of ETF Product Management Steve Schoffstall joined Steve Darling from Proactive to discuss the latest trends shaping the nuclear energy and uranium markets. He provided insights into policy shifts, investor sentiment, and long-term growth drivers in the sector. Schoffstall highlighted the potential impact of former U.S. President Donald Trump’s policies on nuclear energy, noting a strong focus on energy independence, grid security, and an accelerated expansion of nuclear power. He pointed out that newly appointed U.S. Secretary of Energy Chris Wright is already taking steps to support the sector, including advancing research into next-generation nuclear reactors and streamlining permitting processes to accelerate project development. Investor interest in uranium and nuclear-focused ETFs remains robust despite recent market volatility driven by geopolitical factors. Schoffstall also addressed the challenges posed by recent tariff changes, including a 10% tariff on Canadian uranium and a 17.5% increase in duties on enriched uranium from China. These developments are introducing uncertainty for utilities and fuel procurement strategies. Looking ahead, Schoffstall pointed to major long-term demand drivers, including projected electricity demand growth and an ongoing uranium supply deficit. Despite short-term price fluctuations, he remains optimistic about uranium miners, as investors continue to recognize strong fundamentals and future opportunities in the sector. With increasing government support and rising demand for nuclear power, Sprott sees uranium as a key asset for energy security and long-term investment growth. #proactiveinvestors #hanetf #UraniumMinersETF #NuclearEnergy #SprottJuniorUranium# Uranium #ETFs #Investing #EnergyMarkets #Sprott #Mining #CleanEnergy #StockMarket #Commodities…
P
Proactive - Interviews for investors

1 Falcon Gold begins continues drilling program at for Great Burnt Copper Project in Newfoundland 3:04
Falcon Gold CEO Karim Rayani joined Steve Darling from Proactive to announce the commencement of drilling at the company’s Great Burnt Copper Project in Central Newfoundland. Falcon Gold has successfully completed 8 kilometers of road construction leading to the drill site from the government access road, which it shares with Benton Resources. The company has engaged Warrior drilling to do the work. Rayani highlighted that the Great Burnt Greenstone Belt, known for its copper and gold prospects, also hosts the South Pond A and South Pond B copper-gold zones, as well as the End Zone copper prospect along a 14 km mineralized corridor. This corridor occurs along a conductive trend, which extends into Falcon's Great Burnt Copper Property. The initial phase of the drilling program will be 10 holes and will focus on priority targets identified through geophysics and historical drilling, with the goal of expanding known mineralization and testing new high-potential zones along the interpreted structure. #proactiveinvestors #falcongoldcorp #tsxv #fg #otcqb #fgldf #CopperExploration #NewfoundlandMining #KarimRayani #VMSDiscovery #CopperProject #MiningNews #ProactiveInvestors #GreatBurntProject #ExplorationDrilling #BentonResources #investmentproperty #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews…
P
Proactive - Interviews for investors

Suvo Strategic Minerals Ltd has extended its offtake agreement with Chaozhou Chengcheng Industrial Co. for an additional five years, ensuring continued supply of hydrous kaolin from the Pittong operation until February 2030. The agreement, valued at approximately A$6.56 million, includes a take-or-pay arrangement with a minimum order quantity of 8,750 tonnes. The new contract marks a significant increase from the previous three-year agreement, which covered 4,225 tonnes, incorporating a 25% annual rise in minimum order volumes. The updated terms will take effect from February 2025 while maintaining the same contractual conditions. This extension follows Suvo’s recent renewal of a major sales contract with Norske Skog for another three years, reinforcing demand for its hydrous kaolin product. The company attributes the increased order volumes to a successful marketing campaign throughout China. Suvo anticipates significant growth in sales volumes this year, supported by rising demand from major customers. Additionally, the Pittong operations reported positive EBITDA of A$510,000 and a net profit of A$390,000 last quarter. Suvo continues to explore further product development opportunities to expand kaolin sales and generate positive cash flow. #SuvoStrategicMinerals, #Kaolin, #Mining, #IndustrialMinerals, #Manufacturing, #MiningIndustry, #ChinaTrade, #ResourceSector, #HydrousKaolin, #EconomicGrowth, #Commodities, #MarketExpansion #ASX #ProactiveInvestors…
Benvenuto su Player FM!
Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.